$375 Million is the total value of Samsara BioCapital, LLC's 57 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 17.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $90,281,000 | +20.2% | 5,161,888 | +12.4% | 24.07% | +27.2% |
| NKTX | Buy | NKARTA INC | $35,334,000 | +52.6% | 2,868,035 | +41.0% | 9.42% | +61.6% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $25,248,000 | +476.7% | 4,598,828 | +1254.1% | 6.73% | +510.7% |
| GRPH | Buy | GRAPHITE BIO INC | $23,263,000 | -43.5% | 8,459,314 | +4.8% | 6.20% | -40.2% |
| Buy | ARCELLX INC | $19,234,000 | +37.2% | 1,063,835 | +6.4% | 5.13% | +45.3% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $10,786,000 | -25.9% | 1,565,526 | 0.0% | 2.88% | -21.6% | |
| LYRA | New | LYRA THERAPEUTICS INC | $10,041,000 | – | 1,777,251 | +100.0% | 2.68% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $9,719,000 | -29.0% | 696,171 | -12.3% | 2.59% | -24.8% |
| ISEE | Sell | IVERIC BIO INC | $9,717,000 | -54.3% | 1,010,051 | -20.0% | 2.59% | -51.6% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $8,848,000 | -15.1% | 640,688 | 0.0% | 2.36% | -10.1% | |
| STRO | SUTRO BIOPHARMA INC | $8,730,000 | -36.6% | 1,675,579 | 0.0% | 2.33% | -32.9% | |
| RAIN | Sell | RAIN THERAPEUTICS INC | $8,677,000 | +8.9% | 1,560,652 | -0.7% | 2.31% | +15.3% |
| New | HILLEVAX INC | $8,335,000 | – | 762,577 | +100.0% | 2.22% | – | |
| TIL | Sell | INSTIL BIO INC | $8,262,000 | -61.4% | 1,788,280 | -10.2% | 2.20% | -59.2% |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $8,248,000 | -51.2% | 1,693,736 | -10.1% | 2.20% | -48.3% |
| New | PEPGEN INC | $6,465,000 | – | 651,050 | +100.0% | 1.72% | – | |
| IMCR | IMMUNOCORE HLDGS PLCads | $6,006,000 | +24.8% | 160,963 | 0.0% | 1.60% | +32.1% | |
| ZYME | ZYMEWORKS INC | $5,146,000 | -19.1% | 970,987 | 0.0% | 1.37% | -14.3% | |
| JYAC | JIYA ACQUISITION CORP | $5,010,000 | +0.5% | 507,041 | 0.0% | 1.34% | +6.4% | |
| Sell | IO BIOTECH INC | $4,709,000 | -20.7% | 1,008,437 | -10.0% | 1.26% | -16.1% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $4,656,000 | -16.0% | 1,111,112 | 0.0% | 1.24% | -11.1% | |
| JANX | Sell | JANUX THERAPEUTICS INC | $4,401,000 | -25.5% | 360,414 | -12.5% | 1.17% | -21.1% |
| Buy | DICE THERAPEUTICS INC | $3,934,000 | -10.0% | 253,466 | +10.9% | 1.05% | -4.6% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $3,778,000 | -35.2% | 480,000 | 0.0% | 1.01% | -31.4% | |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $3,516,000 | +75.0% | 196,425 | -3.0% | 0.94% | +85.2% |
| DBTX | Sell | DECIBEL THERAPEUTICS INC | $3,375,000 | +34.4% | 801,629 | -3.0% | 0.90% | +42.4% |
| BLSA | BCLS ACQUISITION CORP | $2,970,000 | +0.3% | 300,000 | 0.0% | 0.79% | +6.3% | |
| TANGO THERAPEUTICS INC | $2,854,000 | -40.2% | 630,000 | 0.0% | 0.76% | -36.7% | ||
| IGMS | IGM BIOSCIENCES INC | $2,789,000 | -32.5% | 154,664 | 0.0% | 0.74% | -28.6% | |
| VIRX | Sell | VIRACTA THERAPEUTICS INC | $2,676,000 | -20.9% | 689,709 | -3.0% | 0.71% | -16.3% |
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $2,181,000 | -43.5% | 267,996 | -50.3% | 0.58% | -40.2% |
| BOLT | BOLT BIOTHERAPEUTICS INC | $2,140,000 | -25.6% | 1,049,153 | 0.0% | 0.57% | -21.3% | |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $2,130,000 | -7.9% | 304,715 | +8.9% | 0.57% | -2.4% |
| ALXO | ALX ONCOLOGY HLDGS INC | $2,126,000 | -52.1% | 262,786 | 0.0% | 0.57% | -49.3% | |
| ALBO | ALBIREO PHARMA INC | $1,986,000 | -33.4% | 100,000 | 0.0% | 0.53% | -29.6% | |
| SYRS | SYROS PHARMACEUTICALS INC | $1,829,000 | -19.1% | 1,899,616 | 0.0% | 0.49% | -14.2% | |
| SCIENCE 37 HOLDINGS INC | $1,809,000 | -62.4% | 900,000 | 0.0% | 0.48% | -60.2% | ||
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,609,000 | -64.3% | 659,409 | 0.0% | 0.43% | -62.2% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $1,433,000 | -64.0% | 345,293 | 0.0% | 0.38% | -61.8% | |
| EQ | EQUILLIUM INC | $1,256,000 | -35.2% | 615,541 | 0.0% | 0.34% | -31.4% | |
| VTVT | VTV THERAPEUTICS INCcl a | $1,227,000 | +3.9% | 1,635,509 | 0.0% | 0.33% | +10.1% | |
| NVAX | NOVAVAX INCcall | $1,203,000 | -30.2% | 23,400 | 0.0% | 0.32% | -26.0% | |
| ELEV | Sell | ELEVATION ONCOLOGY INC | $1,163,000 | -50.5% | 830,565 | -10.9% | 0.31% | -47.5% |
| NVAX | Sell | NOVAVAX INC | $1,093,000 | -45.3% | 21,244 | -21.7% | 0.29% | -42.1% |
| SURROZEN INC | $900,000 | -0.3% | 300,000 | 0.0% | 0.24% | +5.7% | ||
| TERN | TERNS PHARMACEUTICALS INC | $717,000 | -16.5% | 289,068 | 0.0% | 0.19% | -11.6% | |
| BCEL | ATRECA INC | $710,000 | -43.6% | 396,835 | 0.0% | 0.19% | -40.4% | |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $547,000 | -83.6% | 22,204 | -62.5% | 0.15% | -82.6% |
| ALLK | ALLAKOS INC | $539,000 | -45.1% | 172,089 | 0.0% | 0.14% | -41.7% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $446,000 | -78.1% | 883,720 | 0.0% | 0.12% | -76.8% | |
| ALVR | ALLOVIR INC | $321,000 | -42.3% | 82,336 | 0.0% | 0.09% | -38.6% | |
| KRON | KRONOS BIO INC | $284,000 | -49.7% | 78,131 | 0.0% | 0.08% | -46.5% | |
| KALA | KALA PHARMACEUTICALS INC | $180,000 | -78.3% | 601,162 | 0.0% | 0.05% | -77.0% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $175,000 | -15.9% | 13,669 | 0.0% | 0.05% | -9.6% | |
| ASTRIA THERAPEUTICS INC | $75,000 | -55.4% | 25,000 | 0.0% | 0.02% | -52.4% | ||
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $37,000 | – | 133,333 | +100.0% | 0.01% | – |
| New | SURROZEN INC*w exp 08/01/203 | $19,000 | – | 99,999 | +100.0% | 0.01% | – | |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -25,000 | -100.0% | -0.02% | – |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -488,632 | -100.0% | -0.15% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -40,550 | -100.0% | -0.16% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -4,031 | -100.0% | -0.17% | – |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -700,421 | -100.0% | -0.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.